Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Genvor to Present at Centri Capital Conference on April 14 Ready to Announce with Confidence?

newsfilecorp.com
OBIO Orchestra BioMed is listed as one of the companies presenting at the Centri Capital Conference. The mention is in the context of a list of 'exciting and disruptive' companies, which is a positive association but doesn't provide specific sentiment about Orchestra BioMed itself. COIN CoinShares is mentioned as one of the companies presenting at the Centri Capital Conference. The article lists it among 'exciting and disruptive' companies, indicating a positive association but without specific details to gauge sentiment. MVBF MVB Financial is included in a list of 'exciting and disruptive' companies presenting at the Centri Capital Conference. This association is positive but lacks specific information about the company's performance or outlook to determine a definitive sentiment. MS Morgan Stanley is listed as a key sponsor of the Centri Capital Conference. While sponsorship indicates involvement, the article does not provide specific details about Morgan Stanley's performance or outlook, resulting in a neutral sentiment. DFIN Donnelley Financial Solutions is mentioned as a key sponsor of the Centri Capital Conference. The article does not offer specific information regarding the company's performance or future prospects, leading to a neutral sentiment. CHDN Chardan is listed as a key sponsor of the Centri Capital Conference. The article mentions their sponsorship but does not provide any specific performance data or future outlook for Chardan, resulting in a neutral sentiment.

Genvor to Present at Centri Capital Conference on April 14 Ready to Announce with Confidence? Woodland, California--(Newsfile Corp. - April 7, 2026) - Genvor (OTCQB: GNVR), a biotechnology company harnessing AI to generate novel peptides for agriculture and human health, will present at the Centri Capital Conference on Tuesday, April 14, at Nasdaq in New York City.

Chad Pawlak, Chief Executive Officer, will discuss the Company's recent performance and future growth plans.

The Centri Capital Conference will gather attendees from across the capital markets ecosystem and investment community, including investment bankers, private equity investors, family offices, and high-net-worth individuals. The highly anticipated conference will feature company presentations and fireside chats, facilitated investor 1:1 meetings, and panel discussions featuring insights from thought leaders in the capital markets space.

Genvor joins a distinguished list of exciting and disruptive presenting companies like Grayscale, Orchestra BioMed, CoinShares, ReserveOne, MVB Financial and many others. Also included in the event at Nasdaq are key sponsors in the capital markets space, including Morgan Stanley, DFIN, Chardan, Gusto, CBIZ, ICR and The Money Channel.

"The companies involved with the Centri Capital Conference embody the innovation and diversity shaping today’s capital markets,” says Michael Aiello, CEO & Managing Partner of Centri. “We are excited to welcome them to Nasdaq for investor 1:1 meetings and meaningful exchanges with leaders from across the industry."

Companies and investors interested in presenting, attending, or sponsoring the Centri Capital Conference can learn more here: www.CentriConsulting.com/capital-conference.

About Genvor

Genvor, Inc. (OTCQB: GNVR) is a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health and wellness. Genvor’s proprietary BioCypher platform designs peptides that enhance crop performance, reduce chemical inputs, and support human recovery and wellness. Through strategic partnerships and a dual-market commercialization model, Genvor is advancing peptide science from field to finish line. For more information, visit www.genvor.com.

About Centri Business Consulting, LLC

Centri Business Consulting provides the highest quality advisory consulting services to its clients by being reliable and responsive to their needs. Centri provides companies with the expertise they need to meet their reporting demands. Centri specializes in financial reporting, internal controls, technical accounting research, valuation, mergers & acquisitions, and tax, CFO and HR advisory services for companies of various sizes and industries. From complex technical accounting transactions to monthly financial reporting, our professionals can offer any organization the specialized expertise and multilayered skillsets to ensure the project is completed timely and accurately.

For additional Information, please contact:

Genvor

Carly Scaduto

+1 (949) 259-4987

Marketing@genvor.com

www.genvor.com

Source: Centri

Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Centri or all companies in the Banking / Financial Services industry.

Genvor to Present at Centri Capital Conference on April 14

2026-04-07 8:00 AM EDT

Chardan to Sponsor Centri Capital Conference on April 14

2026-04-06 12:31 PM EDT

Marketri to Sponsor Centri Capital Conference on April 14

2026-04-06 8:00 AM EDT

Oct 24, 2025

If your company files on SEDAR+, it’s time to prepare for the SEDAR+ fee increase 2025, a significant adjustment approved by the Canadian Securities Administrators (CSA).

Economy, Business and Finance

Energy and Resource

Energy (general)

Banking / Financial Services